Belviq and withdrawn RX anti-obesity drugs
For last decades, several prescription weight loss drugs appeared on international pharmaceutical market. Relatively new drugs for treatment of obesity are Rimonabant and Sibutramine, while the innovative drug is Lorcaserin.
Potential consumers of weight loss products know these drugs under the trade names:
Acomplia diet pills were sold at pharmacies several years ago.
In 2009, they were withdrawn from European market and pharmaceutical markets of other countries. The reason why Acomplia was withdrawn became the results of post-marketing studies that have demonstrated that this drug can cause a severe depression and suicidal thoughts.
Meridia diet pills were available for sale for over 10 years. In 2010, they were also withdrawn from the pharmaceutical markets of most countries worldwide. The reason why Meridia was withdrawn was records saying these diet pills can cause irreversible cardiovascular pathologies.
- Belviq drug was on sale for just 2 years. But the results of its post-marketing studies have not been published yet.
Clinical trials of Belviq have shown that:
Despite the fact that Belviq has been sold within the USA for several years, employees of the European Medicines Agency (EMA) suggest that potential risks of Belviq exceed its benefit for health of an overweight patient.
One of the few European countries, where Phentermine and Amfepramone anorexigenic drugs are still available, is the UK. Amfepramone diet pills are available in the UK under an alternative name – Diethylpropion Hydrochloride, and Phentermine under the trade name – Ionamin.
On the international pharmaceutical market, Phentermine and Diethylpropion diet pills were on sale for 50 years.
If you decide to order Belviq, then you should know that this is the CNS stimulant, which you can buy by a prescription only. Sale and purchase of Belviq without a prescription is considered illegal in many countries of the world.